Compound ID | 1071
Synonym(s): UK31214 | UK-31,214
Class: Aminoglycoside
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Similar in mechinism and efficacy to amikacin, but also shared toxicity problems |
| Institute where first reported: | Pfizer Inc |
| Year first mentioned: | 1979 |
| Highest development stage: | Preclinical |
| Development status: | Inactive |
| Reason dropped: | Toxicity problems in humans |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9872451 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC283780/ |